AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...
Rival treatments had mixed results in the past AstraZeneca sees $3-5 billion peak annual sales for its drug Detailed results to be presented at upcoming medical conference Shares among biggest gainers ...
AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has hit the mark in a pair of phase 3 trials, delivering broad efficacy with a mechanism that yielded mixed data for Roche and ...
Clinical benefits of the interleukin-33 inhibitor were observed in a broad population, including both former and current smokers, regardless of eosinophil levels. Topline results were announced from ...
AstraZeneca’s IL-33 blocker, tozorakimab has significantly reduced the annualised rate of COPD exacerbations as an adjuvant to SoC inhaled therapy over placebo in two Phase III studies. Credit: ...
AstraZeneca didn’t release complete data from the trials, called Oberon and Titania, stating that they will be disclosed at an upcoming medical meeting. Those details will be closely watched.
As filmmaker Priyadarshan gears up for the release of his new horror-comedy film Bhooth Bangla, one film that instantly comes to mind is his iconic 2007 film Bhool Bhulaiyaa. The film had many moments ...
Ekta Kapoor has redefined Indian television with her gripping family dramas and supernatural sagas. Her shows like Kyunki Saas Bhi Kabhi Bahu Thi and Naagin shaped prime-time viewing for millions.
In patients with COPD, transitioning from LABA/LAMA to extrafine single-inhaler triple therapy resulted in a 100 mL absolute increase in FEV 1 over 12 months. In moderate to severe chronic obstructive ...
Abstract: Chronic Obstructive Pulmonary Disease (COPD) represents a major global health challenge, with early and accurate diagnosis being essential for improving patient outcomes. Traditional ...
Vidya Herbs USA celebrated the expansion of its Bunnell manufacturing facility's new building in Bunnell on March 12. Vidya USA, an international company, opened its first United States-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results